U.S. markets closed

Zynex, Inc. (ZYXI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
14.13+0.60 (+4.43%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Momentum

Momentum

Previous Close13.53
Open13.59
Bid14.04 x 800
Ask14.18 x 800
Day's Range13.50 - 14.18
52 Week Range7.51 - 29.73
Volume329,573
Avg. Volume735,930
Market Cap491.54M
Beta (5Y Monthly)0.82
PE Ratio (TTM)47.10
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateDec 31, 2018
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Near Fair Value
13% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Zynex Ranked 13th in Revenue Growth Among Medical Device Companies
    PR Newswire

    Zynex Ranked 13th in Revenue Growth Among Medical Device Companies

    Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics today announced it has been ranked 13th in revenue growth among all medical device companies in the U.S. and Canada on Deloitte's 2020 Technology Fast 500. Zynex was ranked 388th for revenue growth between 2016 and 2019 across all companies in North America. Zynex's revenues grew 242% over that period, with 2019 revenue reaching $45.5 million. The company estimates 2020 revenue between $80.0 and $81.0 million. The 2020 Deloitte Technology Fast 500 list can be found at www.fast500.com.

  • Zynex to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
    PR Newswire

    Zynex to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference

    Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics today announced the Company will participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference. Presentations will be available for registered attendees via the Piper Sandler conference site from November 23 to December 3. The Company will be participating in 1X1 meetings from December 1st-3rd, meetings may be requested exclusively via Piper Sandler.

  • Zynex Announces Third Quarter 2020 Earnings
    PR Newswire

    Zynex Announces Third Quarter 2020 Earnings

    Revenue increased 69% year over year to $20.0 million